Furthermore, CK2 upregulation precedes hyperphosphorylation of tau in AD patients, and increased CK2 expression is highly correlated with hyperphosphorylated tau81 as it inhibits SET which subsequently promotes tau phosphorylation83. This evidence concerns the gene MAPT and Alzheimer disease.